Mabpharm Limited logo

Mabpharm Limited

HKEX:2181.HK

Overview | Financials
Company Name Mabpharm Limited
Symbol 2181.HK
Currency HKD
Price 0.33
Market Cap 1,360,946,400
Dividend Yield 0%
52-week-range 0.25 - 0.55
Industry Biotechnology
Sector Healthcare
CEO Dr. Hao Wang
Website https://www.mabpharm.cn

An error occurred while fetching data.

About Mabpharm Limited

Mabpharm Limited, a biopharmaceutical company, engages in research, development, and production of drugs and biosimilar drugs for allergic diseases, cancers, and autoimmune diseases in China. Its products under the Phase III clinical trial include CMAB007, a recombinant humanized anti-IgE monoclonal antibody for treatment of asthma patients; CMAB009, a recombinant anti-EGFR

Related Stocks

JW (Cayman) Therapeutics Co. Ltd logo

JW (Cayman) Therapeutics Co. Ltd

2126.HK

1.4 HKD

China Pioneer Pharma Holdings Limited logo

China Pioneer Pharma Holdings Limited

1345.HK

2.03 HKD

HBM Holdings Limited logo

HBM Holdings Limited

2142.HK

1.19 HKD

IVD Medical Holding Limited logo

IVD Medical Holding Limited

1931.HK

1.63 HKD

Modern Dental Group Limited logo

Modern Dental Group Limited

3600.HK

3.67 HKD

IntelliCentrics Global Holdings Ltd. logo

IntelliCentrics Global Holdings Ltd.

6819.HK

4.06 HKD

Abbisko Cayman Limited logo

Abbisko Cayman Limited

2256.HK

4.45 HKD

Immunotech Biopharm Ltd logo

Immunotech Biopharm Ltd

6978.HK

1.52 HKD

Sisram Medical Ltd logo

Sisram Medical Ltd

1696.HK

3.6 HKD

Zylox-Tonbridge Medical Technology Co., Ltd. logo

Zylox-Tonbridge Medical Technology Co., Ltd.

2190.HK

11.02 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD